What are you looking for? Fraud AssessmentsCompany LicensingRenewalsStatutory DepositsFeesApplying for Admission & ApplicationsLife and Health DivisionProduct FilingPharmacy Benefit Managers (PBM) Reports, New Mexico Health Access Survey, and BriefsContracted and External ReportsOSI Health Insurance BriefsThe 2023 New Mexico Health Access SurveyResource BinderMiscellaneous Resource Binder ContentSmall Business Health Insurance Premium Relief InitiativePrescription Drug Price TransparencyMember GrievanceHealth Rate ReviewProvider GrievanceHealth Care Affordability FundRequest for Confidential StatusContinuous Quality ImprovementUtilization ManagementProvider CredentialingNetwork AdequacyManaged Health Care Compliance DeadlinesMental Health ParityDebt Collection Protection Act - Provider ResourceVaccine Purchasing ActGuidance for CarriersProperty & CasualtyFinancial RegulationAccredited ReinsurersFinancial StatementsFinancial Statements ArchiveFinancial Examinations Financial Examinations ArchiveFinancial and Market Conduct Examinations - ArchiveTitle Insurance Forms & TablesASR USR Schedules & InstructionsStatistical ReportsIndividuals and AgenciesContinuing Education (CE)Criminal OffenseLicense Status Verification Contact Rolanda Pana Phone: (505) 795-1495 rxtransparency@osi.nm.gov OSI Events Calendar View our calendar of events During the 2023 Legislative Session, the New Mexico State Legislature passed House Bill 33, the Prescription Drug Price Transparency Act. This legislation mandates the New Mexico Office of Superintendent of Insurance (OSI) to collect data from Drug Manufacturers, Pharmacy Services Administrative Organizations (PSAOs), authorized health insurers, and Pharmacy Benefit Managers (PBMs) regarding drug prices and sales. The law also requires OSI to report annually to legislative committees and the public. To fulfill this mandate, OSI will evaluate whether reporting entities meet the established reporting standards, analyze the data, and assess compliance with the Prescription Drug Price Transparency submission criteria. For additional information on these requirements, please refer to NMSA 1978, Section 59A-59A. Prescription Drug Price Transparency Reporting Tool Prescription Drug Price Transparency Act Transmission Guide 2025 (updated 04-28-2025) Prescription Drug Price Transparency Reporting Deadline Delayed (updated 04-24-2025)
November 18, 2025 Bulletins CLARIFICATION ON COORDINATION OF BENEFITS (COB) PROVISIONS FOR MINOR CHILDREN BULLETIN 2025-015: This bulletin is issued in accordance with Sections 59-2-8, 59A-2-10, 59A-16-11(B) and 59A-46-31 NMSA 1978, and 13.1.2 and 13.10.13.11(B)(2) NMAC. The purpose of this bulletin is to clarify the position of the Office of Superintendent of Insurance (OSI) regarding allowable coordination of benefits provisions for a dependent child covered under more than one health insurance […] Read More
December 8, 2025 Announcements Mandatory Reporting Requirements Under the New Mexico Insurance Fraud Act NOTICE TO ALL LICENSEES, INSURERS, AND INSURANCE PROFESSIONALS Subject: Mandatory Reporting Requirements Under the New Mexico Insurance Fraud Act This notice serves as an official reminder that all insurers and licensed insurance professionals are required to comply with the mandatory reporting and cooperation requirements established under the New Mexico Insurance Fraud Act. These obligations […] Read More
November 17, 2025 News Releases NEW MEXICO OFFICE OF THE SUPERINTENDENT OF INSURANCE HOSTS TOWN HALL IN SILVER CITY ON WILDFIRE PREPAREDNESS, MITIGATION AND INSURANCE RESOURCES Contact: Elouisa Macias, Consumer Assistance Bureau ChiefEmail: Elouisa.Macias@osi.nm.gov Santa Fe, NM – On Wednesday, the Office of the Superintendent of Insurance (OSI) hosted a town hall in Silver City, NM related to wildfire preparedness and insurance resources. The town hall was moderated by Elouisa Macias, Consumer Assistance Bureau Chief, Civil Investigations Bureau at OSI. The […] Read More
